Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya.
Sujha SubramanianRainer HilscherRobai GakungaBreda MunozElijah OgolaPublished in: PloS one (2019)
In Kenya, our results indicate that the risk stratified approach to treating hypertension may be cost-effective especially for men and women at a high risk for CVD events, but these results are highly sensitive to the cost of medications. Medication management would require significant financial investment and therefore other interventions, including lifestyle changes, should be evaluated especially for those with elevated blood pressure and overall 10-year risk that is less than 20%.